Carnitine and chromium co-supplementation affects mental health, hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome

Jamilian, M. and Foroozanfard, F. and Kavossian, E. and Aghadavod, E. and Amirani, E. and Mahdavinia, M. and Mafi, A. and Asemi, Z. (2019) Carnitine and chromium co-supplementation affects mental health, hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome. Journal of Psychosomatic Obstetrics and Gynecology.

Full text not available from this repository.
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....
DOI: UNSPECIFIED

Abstract

Objective: The aim of this study was to evaluate the effect of the co-administration of carnitine and chromium on mental health, hormonal, inflammatory and genetic parameters in women with PCOS. Methods: This randomized, double-blinded, placebo-controlled clinical trial was conducted on 54 subjects, aged 18�40 years old. Subjects were randomly allocated to take either 1000 mg/d carnitine plus 200 µg/d chromium as chromium picolinate (n = 26) or placebo (n = 27) for 12 weeks. Results: Carnitine and chromium co-supplementation, compared with the placebo, significantly improved beck depression inventory (β � 0.84; 95 CI, �1.51, �0.17; p = 0.01), general health questionnaire scores (β � 1.13; 95 CI, �2.13, �0.14; p = 0.02) and depression anxiety and stress scale scores (β � 0.96; 95 CI, �0.78, �0.14; p = 0.02). Participants who received carnitine plus chromium supplements had significantly lower total testosterone (β � 0.15 ng/mL; 95 CI, �0.24, �0.06; p = 0.002), hirsutism (β � 0.48; 95 CI, �0.91, �0.06; p = 0.02), high-sensitivity C-reactive protein (hs-CRP) (β � 1.02 mg/L; 95 CI, �1.79, �0.25; p = 0.01), and malondialdehyde (MDA) levels (β � 0.38 µmol/L; 95 CI, �0.56, �0.20; p < 0.001), and higher total antioxidant capacity (TAC) levels (β 107.18 mmol/L; 95 CI, 44.24, 170.12; p = 0.001) compared with the placebo. Moreover, carnitine and chromium co-supplementation upregulated gene expression of interleukin-6 (IL-6) (p = 0.02) and tumor necrosis factor alpha (TNF-α) (p = 0.02) compared with the placebo. Conclusion: Overall, the co-administration of carnitine and chromium for 12 weeks to women with PCOS had beneficial effects on mental health parameters, serum total testosterone, mF-G scores, hs-CRP, TAC and MDA levels, and gene expression of IL-6 and TNF-α. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.

Item Type: Article
Additional Information: cited By 0
Subjects: Medicine
Nutrition
Biochemistry, Genetics and Molecular Biology
Divisions: Faculty of Medicine > Clinical Sciences > Department of , Obstetrics & Gynecology
Depositing User: ART . editor
Date Deposited: 07 May 2019 08:31
Last Modified: 07 May 2019 08:31
URI: http://eprints.kaums.ac.ir/id/eprint/3756

Actions (login required)

View Item View Item